So sir, my question was largely on the NACL side basically. So in the past, you have talked about getting into the CRAMS side of the business in the CPC segment. And in NACL, what I understand is that we do have a facility out there. So are we going to use that? Or we would be like using our own thing or we would be like doing an organic thing in this?
Yes. So by when we can expect the NACL integration to be done in Coromandel?
Hi, sir. Thank you for taking my question. Sir, I just missed the last participant ’s question in terms of the EBITDA per ton guidance. So we are speaking to that Rs. 4,500 to Rs. 5,000 sort of number for FY ‘26, right?
And sir secondly, if you can like help me with this unique grade share to the overall manufactured volumes for Q4 as well as for April ‘26.
Sir, thank you for taking my question. Sir, again on the guidance side basically, so we have been like guiding for a 75% plus sort of like growth in the pharma business and on a consol level, we have been guiding for a single digit sort of growth. We just wanted to have a sense in terms of how one should actually look into the CSM Exports business growth, so how one should actually w ork with the CSM Exports business growth for FY26?
Got it, sir. And sir, any sense on the gross margin guidance?
My first question was largely on gross margin side. So, we have seen a very decent improvement gross margins during this quarter. If you can like throw some light in terms of the reason in the increase in the gross margin and the segmental contribution basically, so which segment has contributed to more to the gross margin level?
So, just wanted to have a sense on this new capping policy basically. In the current scheme of things if you look, looking at the global prices also and the trading business particularly into th e fertilizer segment that is like not at all remunerative. However, what the government is suggesting is that if at all the industry is making any sort of profits over and above the capital limit, they need to return that to the government. So, in the current scheme of things, we are not able to make any sort of profits in the trading side. Can we expect any sort of reversal as and when this gets implemented from the government be it 1st January or 1st April? So, can we expect some sort of like reversal in terms of the current losses which we are making?
Hi, so good day everyone, and thank you for taking my question. So, I have just two questions. Number one on continuing with the previous participant's question on the capex per bed. So can you please provide us with the absolute capex per bed number for both the spoke and the hub hospitals? And if at all, there is any sort of like variation in case of the Greenfield and the Brownfield projects?
Okay. And so, there is any sort of like variation in the spoke and the hub or the cost is the same?